
In the News
Read articles that highlight the groundbreaking research and scientific discoveries being led by MSK’s extraordinary team.

Investigators Look Beyond Immune Checkpoint Inhibitors to Chase Moving Targets in Prostate Cancer

ASH Conference 2021: Follicular Lymphoma Therapeutic Updates

Important Insights for Treating Blood Disorders with Stem Cell Gene Therapy

Experts Forecast Cancer Research and Treatment Advances in 2022

DLBCL: Polatuzumab Vedotin Enhances Progression-Free Survival

Breast cancer-related musculoskeletal pain alleviated with acupuncture

Dr. Rampal on the Importance of Genomic Testing in Myelofibrosis

Dermatology & AI: The need to quantify skin tones

Tweet Chat Recap: Evolving Options for Newly Diagnosed Multiple Myeloma

Tiselizumab’s Mechanism of Action in Patients with Hepatocellular Carcinoma

ASCO CEO Dr. Clifford A. Hudis wraps up our final Morning Minute with some helpful reminders, and his wish for next year.

VISION: Implementation of Lutetium-177-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Approaches Reality

Memorial Sloan Kettering AI spinout, Quest Diagnostics partner to expedite cancer diagnoses

New pill offers hope for some people with lung cancer

Patients with cancer at higher risk for arterial thromboembolic events

Dr. Dang on Cardiac Safety With Pertuzumab/ Trastuzumab in Early-Stage HER2+ Breast Cancer

Low cardiac event rates with dual HER2 blockade in early breast cancer

Dr. Giralt on Omidubicel Vs Standard Umbilical Cord Blood Transplant in Hematologic Malignancies

5 Surprising Facts about Melanoma

Lenvatinib-pembrolizumab combination extends PFS, OS in advanced endometrial cancer

Medical organizations recommend cancer patients, survivors get COVID-19 vaccine

Altered Mental Status in Cancer Patients after COVID-19 Driven by “Cytokine Storm” in CSF

Oncologists Find Controversary With Pembrolizumab Approval in TMB-High Solid Tumors

AACR: Copanlisib + Rituximab Slows Relapsed Indolent Lymphoma